Related Tags >> Millennium Pharmaceuticals multiple myeloma Cancer Drugs pharmaceuticals

Velcade News

Most Popular Velcade Story

ALSO NOTED: GSK cuts 5,000 jobs; Codexis opens Singapore lab; Reliant sets IPO terms;and much more...

October 25, 2007 — 6:59am ET

> The closure of a GlaxoSmithKline's Puerto Rican plant has kicked off the plan to cut 5,000 jobs. Read more...

Velcade Press Releases

Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results
VELCADE Approved Across all Disease Stages for Broad Spectrum of Patients
The NEJM Publishes Millennium's Phase III Results of VELCADE (Bortezomib) for Injection in Previously Untreated Multiple Myeloma
PRESS RELEASE: Phase III Trial of VELCADE for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates
PRESS RELEASE: Phase III Trial in Multiple Myeloma Stopped Early Due to Significant Efficacy Advantage of VELCADE

Latest Headlines

Global demographic trends threaten drug industry
May 14, 2008
Takeda makes $8.8B bid for Millennium
April 10, 2008
Takeda makes $8.8B bid for Millennium
April 10, 2008
Millennium chief scientist takes offbeat approach
April 3, 2008
ALSO NOTED: Genentech options Exelixis inhibitor; Millennium reports positive data for cancer cocktail; Immtech CEO takes a pay
March 14, 2008
Europe moves to reclaim center stage
December 21, 2007
ALSO NOTED: Solvay drug 'approvable'; ChemGenex touts trial results: Asuragen raises $18.5M in venture cash; and much more...
December 10, 2007
ALSO NOTED: GSK cuts 5,000 jobs; Codexis opens Singapore lab; Reliant sets IPO terms;and much more...
October 25, 2007
ALSO NOTED: Cosmo inks deal; GenMab expands cancer program; OPKO acquires rights Phase III drug; and much more...
October 11, 2007
SPOTLIGHT: Positive Velcade data fuels stock rise
September 18, 2007
ALSO NOTED: Titan discontinues Phase II; Poniard lines up $15M; and much more...
October 25, 2006
Velcade wins priority review from FDA
August 8, 2006
ALSO NOTED: Allos gains orphan status for cancer therapy; NICE recommends against Velcade; and much more...
July 25, 2006
ALSO NOTED: FDA fast tracks Nexavar; ImClone, Merck KGaA amend pact; and much more...
July 19, 2006
ALSO NOTED: Merck boosts stake in Schering; Lipitor studied for ALS; and much more...
June 8, 2006
SPOTLIGHT: Millennium Pharmaceuticals reaches $10M milestone
March 8, 2006
ALSO NOTED: Researchers announce cancer cases in AIDS research; FDA meets on Cubicin; and much more...
March 5, 2006
Chutes & Ladders: Levin out, new CEO in at Millennium
June 28, 2005
SPOTLIGHT: Journal posts Velcade data
June 7, 2005

Paid Research Reports

More Research Reports >>